1887

Journal of General Virology header logo

Volume 92, Issue 5

HEPES inhibits the conversion of prion protein in cell culture Free

Abstract

HEPES is a well-known buffering reagent used in cell-culture medium. Interestingly, this compound is also responsible for significant modifications of biological parameters such as uptake of organic molecules, alteration of oxidative stress mechanisms or inhibition of ion channels. While using cell-culture medium supplemented with HEPES on prion-infected cells, it was noticed that there was a significant concentration-dependent inhibition of accumulation of the abnormal isoform of the prion protein (PrP). This effect was present only in live cells and was thought to be related to modification of the PrP environment or biology. These results could modify the interpretation of cell-culture assays of prion therapeutic agents, as well as of previous cell biology results obtained in the field using HEPES buffers. This inhibitory effect of HEPES could also be exploited to prevent contamination or propagation of prions in cell culture.

  • Received:
  • Accepted:
  • Published Online:
© 2011 SGM
Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.027334-0
2011-05-01
2024-04-24
Loading full text...

Full text loading...

/deliver/fulltext/jgv/92/5/1244.html?itemId=/content/journal/jgv/10.1099/vir.0.027334-0&mimeType=html&fmt=ahah

References

  1. Borchelt D. R., Taraboulos A., Prusiner S. B. 1992; Evidence for synthesis of scrapie prion proteins in the endocytic pathway. J Biol Chem 267:16188–16199[PubMed]
     [Google Scholar]
  2. Caughey B., Raymond G. J. 1991; The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive. J Biol Chem 266:18217–18223[PubMed]
     [Google Scholar]
  3. Chasseigneaux S., Pastore M., Britton-Davidian J., Manié E., Stern M. H., Callebert J., Catalan J., Casanova D., Belondrade M. et al. 2008; Genetic heterogeneity versus molecular analysis of prion susceptibility in neuroblasma N2a sublines. Arch Virol 153:1693–1702 [View Article][PubMed]
     [Google Scholar]
  4. Daude N., Marella M., Chabry J. 2003; Specific inhibition of pathological prion protein accumulation by small interfering RNAs. J Cell Sci 116:2775–2779 [View Article][PubMed]
     [Google Scholar]
  5. Forloni G., Iussich S., Awan T., Colombo L., Angeretti N., Girola L., Bertani I., Poli G., Caramelli M. et al. 2002; Tetracyclines affect prion infectivity. Proc Natl Acad Sci U S A 99:10849–10854 [View Article][PubMed]
     [Google Scholar]
  6. Ghaemmaghami S., Phuan P. W., Perkins B., Ullman J., May B. C., Cohen F. E., Prusiner S. B. 2007; Cell division modulates prion accumulation in cultured cells. Proc Natl Acad Sci U S A 104:17971–17976 [View Article][PubMed]
     [Google Scholar]
  7. Good N. E., Izawa S. 1972; Hydrogen ion buffers. Methods Enzymol 24:53–68 [View Article][PubMed]
     [Google Scholar]
  8. Habib A., Tabata M. 2004; Oxidative DNA damage induced by HEPES (2-[4-(2-hydroxyethyl)-1-piperazinyl]ethanesulfonic acid) buffer in the presence of Au(III). J Inorg Biochem 98:1696–1702 [View Article][PubMed]
     [Google Scholar]
  9. Hanrahan J. W., Tabcharani J. A. 1990; Inhibition of an outwardly rectifying anion channel by HEPES and related buffers. J Membr Biol 116:65–77 [View Article][PubMed]
     [Google Scholar]
  10. Kihara H., Tsay K. K., Fluharty A. L. 1983; Effect of Hepes on the fibroblast cerebroside sulfate loading test. Biochem Med 29:278–284 [View Article][PubMed]
     [Google Scholar]
  11. Kirsch M., Lomonosova E. E., Korth H. G., Sustmann R., de Groot H. 1998; Hydrogen peroxide formation by reaction of peroxynitrite with HEPES and related tertiary amines. Implications for a general mechanism. J Biol Chem 273:12716–12724 [View Article][PubMed]
     [Google Scholar]
  12. Kocisko D. A., Caughey B. 2006; Searching for anti-prion compounds: cell-based high-throughput in vitro assays and animal testing strategies. Methods Enzymol 412:223–234 [View Article][PubMed]
     [Google Scholar]
  13. Lehmann S., Pastore M., Rogez-Kreuz C., Richard M., Belondrade M., Rauwel G., Durand F., Yousfi R., Criquelion J. et al. 2009; New hospital disinfection processes for both conventional and prion infectious agents compatible with thermosensitive medical equipment. J Hosp Infect 72:342–350 [View Article][PubMed]
     [Google Scholar]
  14. Lelong I. H., Rebel G. 1998; In vitro taurine uptake into cell culture influenced by using media with or without CO2 . J Pharmacol Toxicol Methods 39:211–220 [View Article][PubMed]
     [Google Scholar]
  15. Li Q.-Q., Cao X.-X., Xu J.-D., Chen Q., Wang W.-J., Tang F., Chen Z.-Q., Liu X.-P., Xu Z.-D. 2009; The role of P-glycoprotein/cellular prion protein interaction in multidrug-resistant breast cancer cells treated with paclitaxel. Cell Mol Life Sci 66:504–515 [View Article][PubMed]
     [Google Scholar]
  16. Liu Y., Ritter C., Riek R., Schubert D. 2006; The formation of bioactive amyloid species by prion proteins in vitro and in cells. Neurosci Lett 406:200–204 [View Article][PubMed]
     [Google Scholar]
  17. Lleu P. L., Rebel G. 1989; Effect of HEPES on the taurine uptake by cultured glial cells. J Neurosci Res 23:78–86 [View Article][PubMed]
     [Google Scholar]
  18. Luo S., Pal D., Shah S. J., Kwatra D., Paturi K. D., Mitra A. K. 2010; Effect of HEPES buffer on the uptake and transport of P-glycoprotein substrates and large neutral amino acids. Mol Pharm 7:412–420 [View Article][PubMed]
     [Google Scholar]
  19. Mangé A., Nishida N., Milhavet O., McMahon H. E., Casanova D., Lehmann S. 2000; Amphotericin B inhibits the generation of the scrapie isoform of the prion protein in infected cultures. J Virol 74:3135–3140 [View Article][PubMed]
     [Google Scholar]
  20. Marr R. A., Guan H., Rockenstein E., Kindy M., Gage F. H., Verma I., Masliah E., Hersh L. B. 2004; Neprilysin regulates amyloid β peptide levels. J Mol Neurosci 22:5–11 [View Article][PubMed]
     [Google Scholar]
  21. Milhavet O., McMahon H. E., Rachidi W., Nishida N., Katamine S., Mangé A., Arlotto M., Casanova D., Riondel J. et al. 2000; Prion infection impairs the cellular response to oxidative stress. Proc Natl Acad Sci U S A 97:13937–13942 [View Article][PubMed]
     [Google Scholar]
  22. Milhavet O., Casanova D., Chevallier N., McKay R. D., Lehmann S. 2006; Neural stem cell model for prion propagation. Stem Cells 24:2284–2291 [View Article][PubMed]
     [Google Scholar]
  23. Nishida N., Harris D. A., Vilette D., Laude H., Frobert Y., Grassi J., Casanova D., Milhavet O., Lehmann S. 2000; Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein. J Virol 74:320–325 [View Article][PubMed]
     [Google Scholar]
  24. Otero D. H., Wilbekin F., Meyer E. M. 1985; Effects of 4-(2-hydroxyethyl)-1-piperazine-ethanesulfonic acid (AH5183) on rat cortical synaptosome choline uptake, acetylcholine storage and release. Brain Res 359:208–214 [View Article][PubMed]
     [Google Scholar]
  25. Raymond G. J., Olsen E. A., Lee K. S., Raymond L. D., Bryant P. K. III, Baron G. S., Caughey W. S., Kocisko D. A., McHolland L. E. et al. 2006; Inhibition of protease-resistant prion protein formation in a transformed deer cell line infected with chronic wasting disease. J Virol 80:596–604 [View Article][PubMed]
     [Google Scholar]
  26. Relaño-Ginés A., Gabelle A., Lehmann S., Milhavet O., Crozet C. 2009; Gene and cell therapy for prion diseases. Infect Disord Drug Targets 9:58–68[PubMed] [CrossRef]
     [Google Scholar]
  27. Salmon P., Trono D. 2006; Production and titration of lentiviral vectors. Curr Protoc Neurosci Chapter 4:Unit 4.21[PubMed]
     [Google Scholar]
  28. Schneider B., Mutel V., Pietri M., Ermonval M., Mouillet-Richard S., Kellermann O. 2003; NADPH oxidase and extracellular regulated kinases 1/2 are targets of prion protein signaling in neuronal and nonneuronal cells. Proc Natl Acad Sci U S A 100:13326–13331 [View Article][PubMed]
     [Google Scholar]
  29. Shyng S. L., Huber M. T., Harris D. A. 1993; A prion protein cycles between the cell surface and an endocytic compartment in cultured neuroblastoma cells. J Biol Chem 268:15922–15928[PubMed]
     [Google Scholar]
  30. Shyng S. L., Lehmann S., Moulder K. L., Harris D. A. 1995; Sulfated glycans stimulate endocytosis of the cellular isoform of the prion protein, PrPC, in cultured cells. J Biol Chem 270:30221–30229 [View Article][PubMed]
     [Google Scholar]
  31. Solassol J., Crozet C., Lehmann S. 2003; Prion propagation in cultured cells. Br Med Bull 66:87–97 [View Article][PubMed]
     [Google Scholar]
  32. Solassol J., Crozet C., Perrier V., Leclaire J., Béranger F., Caminade A. M., Meunier B., Dormont D., Majoral J. P., Lehmann S. 2004; Cationic phosphorus-containing dendrimers reduce prion replication both in cell culture and in mice infected with scrapie. J Gen Virol 85:1791–1799 [View Article][PubMed]
     [Google Scholar]
  33. Supattapone S., Nguyen H. O., Cohen F. E., Prusiner S. B., Scott M. R. 1999; Elimination of prions by branched polyamines and implications for therapeutics. Proc Natl Acad Sci U S A 96:14529–14534 [View Article][PubMed]
     [Google Scholar]
  34. Taraboulos A., Raeber A. J., Borchelt D. R., Serban D., Prusiner S. B. 1992; Synthesis and trafficking of prion proteins in cultured cells. Mol Biol Cell 3:851–863[PubMed] [CrossRef]
     [Google Scholar]
  35. Williamson J. D., Cox P. 1968; Use of a new buffer in the culture of animal cells. J Gen Virol 2:309–312 [View Article][PubMed]
     [Google Scholar]
  36. Zigler J. S. Jr, Lepe-Zuniga J. L., Vistica B., Gery I. 1985; Analysis of the cytotoxic effects of light-exposed HEPES-containing culture medium. In Vitro Cell Dev Biol 21:282–287 [View Article][PubMed]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.027334-0
Loading
HEPES inhibits the conversion of prion protein in cell culture
J. Gen. Virol. 92, 1244 (2011); https://doi.org/10.1099/vir.0.027334-0
/content/journal/jgv/10.1099/vir.0.027334-0
/content/journal/jgv/10.1099/vir.0.027334-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error